BD Biomark Diagnostics Inc. Stock: price and directors' dealings · Canada · SEDIFollow the Biomark Diagnostics Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Operating in the Health Care sector, Biomark Diagnostics Inc. has logged 34 reports. Market capitalisation: €52.5m. The latest transaction was filed on 28 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Maula Bux, Rashid Ahmed. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
All Executives34 Thresholds0 Prospectus0 Other0
Declarations 34 total
▲ 5 - Senior Officer of Issuer · Executives · 28 Aug 2026
1,200 shares @ CA$0.47 Common Shares SEDI:4770128 Canonical exit: 26 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 24 Aug 2026
2,500 shares @ CA$0.48 Common Shares SEDI:4770127 Canonical exit: 22 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 28 Aug 2026
1,300 shares @ CA$0.495 Common Shares SEDI:4770126 Canonical exit: 26 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 24 Aug 2026
4,500 shares @ CA$0.48 Common Shares SEDI:4770125 Canonical exit: 22 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 19 Aug 2026
1,000 shares @ CA$0.57 0.0011% mcap 1.4% of flow Common Shares SEDI:4767666 Canonical exit: 17 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Aug 2026
1,100 shares @ CA$0.59 0.0011% mcap 1.6% of flow Common Shares SEDI:4764850 Canonical exit: 12 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Aug 2026
1,100 shares @ CA$0.55 0.0010% mcap 1.5% of flow Common Shares SEDI:4764849 Canonical exit: 11 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 11 Aug 2026
1,000 shares @ CA$0.55 0.0010% mcap 1.3% of flow Common Shares SEDI:4764848 Canonical exit: 9 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 14 Aug 2026
1,000 shares @ CA$0.57 0.0010% mcap 4.4% of flow Common Shares SEDI:4764847 Canonical exit: 12 Nov 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 30 Jul 2026
1,000 shares @ CA$0.56 0.0010% mcap 1.4% of flow Common Shares SEDI:4757537 Canonical exit: 28 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 21 Jul 2026
1,100 shares @ CA$0.55 0.0010% mcap 1.6% of flow Common Shares SEDI:4755767 Canonical exit: 19 Oct 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 24 Jul 2026
500 shares @ CA$0.55 0.0005% mcap 2.2% of flow Common Shares SEDI:4755755 Canonical exit: 22 Oct 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 13 Jul 2026
2,000 shares @ CA$0.55 0.0019% mcap 9.1% of flow Common Shares SEDI:4754036 Canonical exit: 11 Oct 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 13 Jul 2026
9,000 shares @ CA$0.50 0.0077% mcap 37.1% of flow Common Shares SEDI:4754035 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
30,100 shares @ CA$0.50 0.026% mcap 39.1% of flow Common Shares SEDI:4754034 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 16 Jul 2026
12,700 shares @ CA$0.55 0.012% mcap 100.0% of flow Common Shares SEDI:4753282 Canonical exit: 14 Oct 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 3 Jul 2026
2,000 shares @ CA$0.5325 0.0018% mcap 16.2% of flow Common Shares SEDI:4745784 Canonical exit: 1 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 3 Jul 2026
6,350 shares @ CA$0.5148 0.0057% mcap 13.8% of flow Common Shares SEDI:4745782 Canonical exit: 1 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 26 Jun 2026
5,000 shares @ CA$0.541 0.0050% mcap 13.3% of flow Common Shares SEDI:4741158 Canonical exit: 24 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 19 Jun 2026
2,500 shares @ CA$0.55 0.0026% mcap 24.9% of flow Common Shares SEDI:4738231 Canonical exit: 17 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
1,000 shares @ CA$0.54 0.0010% mcap 9.8% of flow Common Shares SEDI:4738229 Canonical exit: 13 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 19 Jun 2026
5,000 shares @ CA$0.55 0.0051% mcap 15.6% of flow Common Shares SEDI:4738228 Canonical exit: 17 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 15 Jun 2026
1,500 shares @ CA$0.55 0.0015% mcap 4.7% of flow Common Shares SEDI:4738226 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 12 Jun 2026
4,000 shares @ CA$0.54 0.0040% mcap 60.3% of flow Common Shares SEDI:4735249 Canonical exit: 10 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Jun 2026
2,000 shares @ CA$0.56 0.0021% mcap 31.4% of flow Common Shares SEDI:4735248 Canonical exit: 8 Sept 2026 (T+90) 25 of 34 declarations
Load more (9 remaining) About Biomark Diagnostics Inc. Biomark Diagnostics Inc. is a company focused on developing diagnostic tests for cancer. It aims to improve patient outcomes through innovative solutions.